Sham | TACSED | TACEX | |
---|---|---|---|
Baseline TAC phenotype | |||
Body weight (g) | 28.2 ± 0.1 | 28.2 ± 0.2 (p = 0.13) | 29.2 ± 0.1 (a: p = 0.95; b: p = 0.18) |
Tibia length (mm) | 17.2 ± 0.05 | 17.5 ± 0.03 (p = 0.89) | 17.2 ± 0.05 (a: p = 0.10; b: p = 0.12) |
Heart weight (mg) | 145.6 ± 1.0 | 201.4 ± 2.8 (p < 0.001) | 213.8 ± 2.8 (a: p < 0.001; b: p = 0.46) |
Heart weight/tibia length (mg/mm) | 8.5 ± 0.1 | 11.6 ± 0.1 (p < 0.001) | 12.4 ± 0.2 (a: p < 0.001; b: p = 0.26) |
EDL mass/TL (mg/mm) | 0.77 ± 0.12 | 0.83 ± 0.05 (p = 0.14) | 0.81 ± 0.05 (a: p = 0.35; b: p = 0.61) |
Functional cardiac parameters | |||
LCCA velocity 2 weeks post TAC (mm/s) | 833.5 ± 15.3 | 333.0 ± 49.5 (a: p < 0.001; b: p = 0.90) | |
RCCA velocity 2 weeks post TAC (mm/s) | 1148.7 ± 154.4 | 1524.1 ± 138.0 (a: p = 0.098; b: p = 0.42) | |
LVEF (%) | 61 ± 5 | 46 ± 6 (p < 0.001) | 47 ± 7 (a: p < 0.001; b: p = 0.76) |
FS (%) | 32 ± 3 | 22 ± 4 (p < 0.001) | 23 ± 4 (a: p < 0.001; b: p = 0.76) |
Diastolic LV volume (µL) | 68.7 ± 5.58 | 103.9 ± 4.9 (p = 0.002) | 107.1 ± 9.6 (a: p = 0.03; b: p = 0.77) |
Systolic LV volume (µL) | 34.6 ± 4.0 | 63.4 ± 5.5 (p < 0.001) | 69.4 ± 10.9 (a: p = 0.007; b: p = 0.63) |
Diastolic LV wall thickness (mm) | 4.3 ± 0.1 | 4.7 ± 0.9 (p = 0.27) | 4.4 ± 0.4 (a: p = 0.097; b: p = 0.69) |
Systolic LV wall thickness (mm) | 1.0 ± 0.1 | 1.1 ± 0.1 (p = 0.64) | 1.1 ± 0.1 (a: p = 0.50; b: p = 0.82) |
Histological evaluation of cardiac remodeling | |||
Relative heart area | 1 | 0.98 ± 0.05 (p = 0.72) | 1.09 ± 0.03 (a: p = 0.022; b: p = 0.053) |
Relative circumference | 1 | 0.98 ± 0.02 (p = 0.45) | 1.07 ± 0.02 (a: p = 0.01; b: p = 0.003) |
Relative LV thickness | 1 | 1.09 ± 0.08 (p = 0.40) | 1.09 ± 0.06 (a: p = 0.23; b:p = 0.97) |
Relative RV thickness | 1 | 0.77 ± 0.08 (p = 0.044) | 0.70 ± 0.06 (a:p = 0.004; b: p = 0.56) |
Cardiomyocyte CSA (µm2) | 50.3 ± 0.8 | 61.6 ± 1.2 (p < 0.001) | 59.6 ± 1.0 (a: p < 0.001; b: p = 0.20) |
Perivascular fibrosis (%) | 1.8 ± 0.1 | 2.0 ± 1.1 (p = 0.75) | 2.6 ± 0.2 (a:p = 0.27; b:p = 0.48) |
Interstitial fibrosis (%) | 0.2 ± 0.1 | 0.4 ± 0.1 (p = 0.51) | 0.3 ± 0.1 (a: p = 0.01; b: p = 0.86) |
Coronary artery diameter (µm) | 27.3 ± 2.0 | 36.6 ± 2.8 (p = 0.008) | 30.8 ± 3.0 (a: p = 0.32; b: p = 0.16) |
Muscle function and remodeling | |||
EDL max. force (N/cm2) | 25.8 ± 5.7 | 28.8 ± 4.7 (p = 0.20) | 28.1 ± 6.6 (a: p = 0.30; b: p = 0.9) |
EDL fiber diameter (µm) | 40.7 ± 1.7 | 35.3 ± 1.6 (p = 0.04) | 37.1 ± 1.4 (a: p = 0.16, b: p = 0.79) |
EDL slow fiber proportion (%) | 2.25 ± 0.41 | 1.81 ± 0.48 (p = 0.78) | 2.63 ± 1.12 (a: p = 0.62; b: p = 0.53) |
EDL fast fiber proportion (%) | 92.7 ± 1.1 | 86.6 ± 07.2 (p = 0.32) | 93.1 ± 4.6 (a: p = 0.84; b: p = 021) |
Soleus fiber diameter (µm) | 44.3 ± 1.9 | 45.8 ± 1.5 (p = 0.74) | 37.8 ± 1.5 (a: p = 0.01; b: p = 0.002) |
Soleus slow fiber proportion (%) | 30.3 ± 3.0 | 33.6 ± 8.5 (p = 0.73) | 29.7 ± 2.6 (a: p = 0.87; b: p = 0.78) |